Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126439122 | 12643912 | 2 | F | 20160812 | 20160811 | 20160825 | EXP | DE-AUROBINDO-AUR-APL-2016-10230 | AUROBINDO | 76.00 | YR | F | Y | 0.00000 | 20160825 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126439122 | 12643912 | 1 | PS | VENLAFAXINE | VENLAFAXINE HYDROCHLORIDE | 1 | 37.5 MG, UNK | 90555 | 37.5 | MG | |||||||||
| 126439122 | 12643912 | 2 | SS | VENLAFAXINE | VENLAFAXINE HYDROCHLORIDE | 1 | 112.5 MG, UNK | 90555 | 112.5 | MG | |||||||||
| 126439122 | 12643912 | 3 | SS | VENLAFAXINE | VENLAFAXINE HYDROCHLORIDE | 1 | Unknown | 75 MG, UNK | 90555 | 75 | MG | ||||||||
| 126439122 | 12643912 | 4 | SS | OLANZAPINE. | OLANZAPINE | 1 | 5 MG AT NIGHT | U | 0 | 5 | MG | ||||||||
| 126439122 | 12643912 | 5 | SS | OLANZAPINE. | OLANZAPINE | 1 | 2.5 MG SECOND DAY OF TREATMENT | U | 0 | 2.5 | MG | ||||||||
| 126439122 | 12643912 | 6 | SS | DABIGATRAN | DABIGATRAN | 1 | Oral | UNK | U | 0 | |||||||||
| 126439122 | 12643912 | 7 | SS | PRADAXA | DABIGATRAN ETEXILATE MESYLATE | 1 | Oral | U | 0 | ||||||||||
| 126439122 | 12643912 | 8 | SS | LORAZEPAM. | LORAZEPAM | 1 | Unknown | 0.5 MG, TWO TIMES A DAY | 0 | .5 | MG | BID | |||||||
| 126439122 | 12643912 | 9 | SS | LORAZEPAM. | LORAZEPAM | 1 | Unknown | 1 MG, UNK | 0 | 1 | MG | ||||||||
| 126439122 | 12643912 | 10 | SS | LORAZEPAM. | LORAZEPAM | 1 | Unknown | 0.75 MG, UNK | 0 | .75 | MG | ||||||||
| 126439122 | 12643912 | 11 | SS | LORAZEPAM. | LORAZEPAM | 1 | Unknown | 0.5 MG, UNK | 0 | .5 | MG | ||||||||
| 126439122 | 12643912 | 12 | SS | LORAZEPAM. | LORAZEPAM | 1 | Unknown | 0.25 MG, UNK | 0 | .25 | MG | ||||||||
| 126439122 | 12643912 | 13 | C | METHOTREXATE. | METHOTREXATE | 1 | Unknown | U | 0 | 15 | MG | ||||||||
| 126439122 | 12643912 | 14 | C | PREDNISOLONE. | PREDNISOLONE | 1 | Unknown | 5 MG, UNK | U | 0 | 5 | MG | |||||||
| 126439122 | 12643912 | 15 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Unknown | 40 MG, UNK | U | 0 | 40 | MG | |||||||
| 126439122 | 12643912 | 16 | C | FESOTERODINE | FESOTERODINE | 1 | Unknown | 8 MG, UNK | U | 0 | 8 | MG | |||||||
| 126439122 | 12643912 | 17 | C | CALCIUM | CALCIUM | 1 | Unknown | 500 MG, UNK | U | 0 | 500 | MG | |||||||
| 126439122 | 12643912 | 18 | C | COLECALCIFEROL | CHOLECALCIFEROL | 1 | Unknown | ONCE/WEEK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126439122 | 12643912 | 1 | Antidepressant therapy |
| 126439122 | 12643912 | 4 | Insomnia |
| 126439122 | 12643912 | 5 | Merycism |
| 126439122 | 12643912 | 6 | Anticoagulant therapy |
| 126439122 | 12643912 | 7 | Deep vein thrombosis |
| 126439122 | 12643912 | 8 | Depression |
| 126439122 | 12643912 | 13 | Rheumatoid arthritis |
| 126439122 | 12643912 | 14 | Product used for unknown indication |
| 126439122 | 12643912 | 15 | Product used for unknown indication |
| 126439122 | 12643912 | 16 | Product used for unknown indication |
| 126439122 | 12643912 | 17 | Product used for unknown indication |
| 126439122 | 12643912 | 18 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126439122 | 12643912 | OT |
| 126439122 | 12643912 | LT |
| 126439122 | 12643912 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126439122 | 12643912 | Seizure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |